Evidence map›Paper›PMID 35751001›Full record

ReviewDrug delivery and translational research2023

Light-responsive biomaterials for ocular drug delivery.

Hend A M Abdelmohsen, Nikki A Copeland, John G Hardy

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Drug delivery and translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hend A M AbdelmohsenDepartment of Chemistry, Lancaster University, Lancaster, LA1 4YB, Lancashire, UK.ORCID 0000-0002-2827-907X
Nikki A CopelandDivision of Biomedical and Life Sciences, Lancaster University, Lancaster, LA1 4YW, Lancashire, UK.ORCID 0000-0002-6204-4717
John G HardyDepartment of Chemistry, Lancaster University, Lancaster, LA1 4YB, Lancashire, UK. j.g.hardy@lancaster.ac.uk.ORCID 0000-0003-0655-2167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Light-responsive biomaterials can be used for the delivery of therapeutic drugs and nucleic acids, where the tunable/precise delivery of payload highlights the potential of such biomaterials for treating a variety of conditions. The translucency of eyes and advances of laser technology in ophthalmology make light-responsive delivery of drugs feasible. Importantly, light can be applied in a non-invasive fashion; therefore, light-triggered drug delivery systems have great potential for clinical impact. This review will examine various types of light-responsive polymers and the chemistry that underpins their application as ophthalmic drug delivery systems.

Indexed as

Biocompatible MaterialsDrug Delivery SystemsPolymersBiocompatible MaterialsPolymersLight-responsiveLight-triggeredOcular drug deliveryPhotobiologyPhotochemistryStimuli-responsive

Identifiers

PMID35751001
PMCPMC10315357

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.